Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
The Readout Loud - Un pódcast de STAT - Jueves
Categorías:
Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?
